![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2019
Klopstock, Thomas; Tricta, Fernando; Neumayr, Lynne; Karin, Ivan; Zorzi, Giovanna; Fradette, Caroline; Kmiec, Tomasz; Buchner, Boriana; Steele, Hannah E.; Horvath, Rita; Chinnery, Patrick F.; Basu, Anna; Kupper, Clemens; Neuhofer, Christiane; Kalman, Bernadette; Dusek, Petr; Yapici, Zuhal; Wilson, Ian; Zhao, Feng; Zibordi, Federica; Nardocci, Nardo; Aguilar, Christine; Hayflick, Susan J.; Spino, Michael; Blamire, Andrew M.; Hogarth, Penelope und Vichinsky, Elliott
(2019):
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.
In: Lancet Neurology, Bd. 18, Nr. 7: S. 631-642
2017
Hogarth, Penelope; Kurian, Manju A.; Gregory, Allison; Csányi, Barbara; Zagustin, Tamara; Kmiec, Tomasz; Wood, Patricia; Klucken, Angelika; Scalise, Natale; Sofia, Francesca; Klopstock, Thomas; Zorzi, Giovanna; Nardocci, Nardo und Hayflick, Susan J.
(2017):
Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).
In: Molecular Genetics and Metabolism, Bd. 120, Nr. 3: S. 278-287